My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

148.13 +0.84 (+0.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery
From Masimo
Via Business Wire
7 Best High-Growth Stocks for Young Investors
The best high-growth stocks for young investors are poised to outperform once again once the markets turn positive. 
Via InvestorPlace
Two-part Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Reduced Length of Hospital Stay for COVID-19 Patients
From Masimo
Via Business Wire
7 Analysts Have This to Say About Masimo
Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues
 
Via Benzinga
New Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors Determine the Severity of Asthma Attacks in Pediatric Patients
From Masimo
Via Business Wire
Masimo's Return on Invested Capital Insights
According to Benzinga Pro, during Q1, Masimo (NASDAQ:MASI) earned $46.59 million, a 31.74% increase from the preceding quarter. Masimo's sales decreased to $304.24 million, a 7.12% change since Q4. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Masimo Reports First Quarter 2022 Financial Results
From Masimo
Via Business Wire
Supply Chain Challenges To Hit Masimo's Q1 FY22 Sales
 
Via Benzinga
Why Jim Cramer Recommends Buying Norwegian Cruise Line
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norwegian Cruise Line Holdings Ltd. (NYSE... 
Via Benzinga
Masimo's Earnings Outlook
Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an... 
Via Benzinga
Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers
From Masimo
Via Business Wire
Masimo SedLine® Brain Function Monitoring Reduced the Use of Anesthetic Agents and Opioids in a Study on Patients Undergoing Cardiac Surgery
From Masimo
Via Business Wire
New JAMA Article Highlights the Outcome and Safety Benefits of Remote Patient Monitoring During the Pandemic and Beyond
From Masimo
Via Business Wire
Masimo Closes Acquisition of Sound United
From Masimo
Via Business Wire
10 Biggest Price Target Changes For Thursday
Goldman Sachs raised the price target on Consolidated Edison, Inc. (NYSE: ED) from $65 to $83. Consolidated Edison shares rose 0.5% to trade at $95.24 on Thursday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Upgrades 
Via Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Masimo Announces Certain Preliminary First Quarter 2022 Financial Results and Reaffirms Full-Year 2022 Revenue Guidance
From Masimo Corporation
Via Business Wire
New Study Finds That Noninvasive and Continuous Hemoglobin Improved Transfusion Management and Outcomes in Pediatric Patients
From Masimo
Via Business Wire
Analyst Ratings For Masimo
Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings... 
Via Benzinga
Masimo Debuts Telehealth for Patient SafetyNet™ at HIMSS 2022 Global Health Conference
From Masimo
Via Business Wire
Masimo's SedLine Brain Function Monitor Sensor Scores FDA Approval For Pediatric Use
The FDA has FDA cleared Masimo Corp's (NASDAQ: MASI) SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG... 
Via Benzinga
Masimo Announces FDA Clearance of Pediatric Indication for SedLine® Brain Function Monitoring and the SedLine Pediatric EEG Sensor
From Masimo
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022
Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Rhythm Pharmaceuticals (NASDAQ:RYTM) stock increased by 16.4% to $7.72 during Thursday's regular session. The current volume of 639.5K shares is 152.7% of... 
Via Benzinga
56 Biggest Movers From Yesterday
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... 
Via Benzinga
Masimo Whale Trades Spotted
Someone with a lot of money to spend has taken a bullish stance on Masimo (NASDAQ:MASI). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Mid-Afternoon Market Update: US Stocks Pare Losses; S&P 500 Turns Higher
US stocks pared losses toward the end of trading on Wednesday following the release of Fed minutes. 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.